Windlas Biotech appoints Dr. Tarashree Singhal as Additional Independent Woman Director effective May 5, 2026, subject to shareholder approval.
Mr. Srinivasan Venkataraman ceases to be an Independent Director upon completion of his five-year term on May 5, 2026.
The board change is intimated under SEBI Listing Regulations, with Dr. Singhal bringing 26 years of medical practice experience.
The appointment is for a five-year term based on the recommendation of the Nomination & Remuneration Committee.